Millipore Sigma Vibrant Logo

341599 FGF-10, Human, Recombinant

FGF-10, Human, Recombinant : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
View Products on Sigmaaldrich.com
341599
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Purity
      ≥97% by SDS-PAGE
      Description
      OverviewRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      Catalogue Number341599
      Brand Family Calbiochem®
      References
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Product Information
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      Purity≥97% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      341599 0

      Documentation

      FGF-10, Human, Recombinant FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      FGF-10, Human, Recombinant Certificats d'analyse

      TitreNuméro de lot
      341599

      Références bibliographiques

      Aperçu de la référence bibliographique
      Beenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-Sepmtember-2011 RFH
      DescriptionRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Purity≥97% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS containing at least 0.1% human or bovine serum albumin.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.